Written and maintained by CASRAI Editorial Board
Published · Last updated
This page describes products and general use; it is not medical advice.
On this page
A closed system transfer device (CSTD) is a drug transfer device that NIOSH describes as one that “mechanically prohibits the transfer of environmental contaminants into the system and the escape of the hazardous drug or vapor concentrations outside the system.” It is used where hazardous drugs, such as chemotherapy agents, are prepared and given. This guide is for pharmacy and infusion staff, supply buyers and students who need to know what the device class is, how the two design concepts differ, and what testing and classification actually exist behind the marketing claims. Source: NIOSH, Closed System Drug-Transfer Device (CSTD) Research, page dated February 9, 2024, checked October 31, 2026.
What a closed system transfer device is
A CSTD is a transfer device used while handling hazardous drugs. Its stated purpose is to keep the drug, and its vapors, from escaping into the work environment while the drug is moved between containers. NIOSH says that when appropriately designed and used, CSTDs offer enhanced protection against potentially hazardous exposures to healthcare workers during compounding and administration of hazardous drugs.
Who uses it: pharmacy staff who compound hazardous drugs and the staff who administer those doses. NIOSH recommends use of a CSTD throughout the hazardous drug-handling chain, from pharmaceutical compounding to patient dose administration.
How CSTDs are built: two design concepts
NIOSH states that CSTDs currently generally follow one of two design concepts: a physical barrier, or an air-cleaning technology, used to prevent the escape of hazardous drugs into the work environment. Which concept a product uses matters later, because the available NIOSH test work treats the two differently.
Types of CSTD
| Design concept | What NIOSH says it does | Relevance to NIOSH test work |
|---|---|---|
| Physical-barrier type | Uses a physical barrier to prevent escape of hazardous drugs into the work environment | NIOSH’s first draft protocol (2015) tested barrier-type devices; NIOSH calls it a robust test protocol for barrier-type CSTDs |
| Air-cleaning type | Uses air-cleaning technology to prevent escape of hazardous drugs into the work environment | The first draft protocol “was not designed to test air-cleaning type CSTDs”; NIOSH sought stakeholder input on a protocol for them in 2016 |
Source for both rows: NIOSH, Closed System Drug-Transfer Device (CSTD) Research (checked 2026-10-31). Brand-by-brand feature lists are deliberately left out; this page does not rank or recommend products.
How FDA classifies these devices
In the openFDA device classification database (record pulled October 30, 2026), product code ONB is named “Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System.” It is listed as device class 2 under regulation number 880.5440, in the General Hospital panel, with the definition: reconstitute and transfer antineoplastic and other hazardous drugs in a healthcare setting, indicated to reduce exposure of healthcare personnel to chemotherapy agents in a healthcare setting.
Regulation 880.5440 is titled “Intravascular administration set” in 21 CFR. The regulation text itself does not use the term CSTD; the connection comes from FDA’s product-code assignment in openFDA. Sources: openFDA device classification, product code ONB and 21 CFR 880.5440 (Cornell LII), checked October 31, 2026.
Testing and standards: what exists and what does not
This is where many product claims get loose, so the exact NIOSH statements are worth knowing:
- NIOSH says CSTD performance standards exist that apply to sterile practice and patient protection, but “no CSTD performance standards are available for drug containment.”
- NIOSH is developing a test protocol to evaluate a CSTD’s containment of hazardous drugs. The 2015 draft tested five commercially available barrier-type CSTDs with 70% isopropyl alcohol as the challenge agent, in an environmental test chamber with a gas analyzer.
- A unified protocol covering both barrier and air-cleaning types was released only as an early draft in September 2016. NIOSH says a unified test protocol “has not been finalized” and that it does not anticipate publishing pass/fail criteria as part of the final protocol.
- NIOSH says it is aware of articles and advertisements reporting CSTD results that cite the draft unified protocol, and that results from the initial draft protocol should not supersede results under a future final NIOSH protocol.
In plain terms, based on those statements, there is no finalized NIOSH test or pass/fail standard against which a device could be called “NIOSH-approved.” That is an editorial reading of NIOSH’s wording; read the NIOSH page itself for the full context.
How to choose: what the sources actually support
The NIOSH and FDA material cited here gives no sizing or selection criteria, so there is no size table and no ranking. What NIOSH does state, and what a buyer can therefore ask about, is limited to these points:
- Design concept. Is the device a physical-barrier or an air-cleaning type? NIOSH’s initial draft protocol applies to barrier types only.
- Which test a performance claim cites. A claim based on the 2015 draft protocol, or on the 2016 draft unified protocol, is a claim against a draft. NIOSH notes the unified protocol is incomplete.
- Which kind of standard is meant. Standards for sterile practice and patient protection are a different thing from a drug-containment standard, which NIOSH says is not available.
Safe use and handling basics
NIOSH states that CSTDs should not be the only means of worker protection. They should be used as part of a hazardous drug safety program and in conjunction with other engineering controls. Manufacturer instructions for use govern how a specific device is assembled and used; follow the instructions and the facility’s own hazardous drug policy. For waste and stocking context see chemotherapy waste disposal, the NIOSH hazardous drugs list and the oncology infusion center supply checklist.
Common mistakes
- Treating a CSTD as a replacement for the rest of a hazardous drug safety program. NIOSH says it should not be the only protection.
- Reading “passed the NIOSH protocol” as a certification. NIOSH has said the unified protocol is not finalized.
- Assuming the barrier and air-cleaning types were tested the same way. The first NIOSH draft protocol covered barrier types only.
- Assuming FDA classification (product code ONB, class 2) is the same as a NIOSH containment rating. They are separate things.
FAQ
What does CSTD stand for?
Closed system transfer device; NIOSH’s formal term is Closed System Drug-Transfer Device. Both refer to the same device class.
Does a CSTD replace other protective equipment or controls?
No. NIOSH says CSTDs should not be the only means of worker protection and should be used with other engineering controls as part of a hazardous drug safety program.
Is there a NIOSH standard for CSTDs?
Not a finalized one. As of the NIOSH page dated February 9, 2024, NIOSH was still developing a unified test protocol and did not anticipate publishing pass/fail criteria with it. Related reading: outpatient infusion center supply checklist and clinical trial pharmacy supply checklist.
What are the types of CSTD?
NIOSH describes two design concepts: physical barrier and air-cleaning technology.
How does FDA classify CSTDs?
Per openFDA, under product code ONB as a class 2 device, regulation number 880.5440.
Sources
- NIOSH, Closed System Drug-Transfer Device (CSTD) Research, Feb. 9, 2024 (checked 2026-10-31).
- openFDA device classification, product code ONB (pulled 2026-10-30, checked 2026-10-31).
- 21 CFR 880.5440, Intravascular administration set (checked 2026-10-31).







